Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Gains from Investment Securities (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Gains from Investment Securities for 7 consecutive years, with -$1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 94.04% to -$1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.9 million, a 89.11% decrease, with the full-year FY2023 number at $88.5 million, up 303.95% from a year prior.
  • Gains from Investment Securities was -$1.6 million for Q3 2025 at Select Medical Holdings, up from -$4.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $178.1 million in Q4 2021 to a low of -$26.8 million in Q3 2024.
  • A 5-year average of $15.1 million and a median of $4.6 million in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 1982.35% in 2023, then tumbled 1142.49% in 2025.
  • Select Medical Holdings' Gains from Investment Securities stood at $178.1 million in 2021, then tumbled by 97.42% to $4.6 million in 2022, then soared by 1982.35% to $95.5 million in 2023, then crashed by 85.41% to $13.9 million in 2024, then tumbled by 111.45% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Gains from Investment Securities are -$1.6 million (Q3 2025), -$4.9 million (Q2 2025), and $1.5 million (Q1 2025).